Blood transcriptome based biomarkers for human circadian phase

Abstract

Diagnosis and treatment of circadian rhythm sleep-wake disorders both require assessment of circadian phase of the brain’s circadian pacemaker. The gold-standard univariate method is based on collection of a 24-hr time series of plasma melatonin, a suprachiasmatic nucleus-driven pineal hormone. We developed and validated a multivariate whole-blood mRNA-based predictor of melatonin phase which requires few samples. Transcriptome data were collected under normal, sleep-deprivation and abnormal sleep-timing conditions to assess robustness of the predictor. Partial least square regression (PLSR), applied to the transcriptome, identified a set of 100 biomarkers primarily related to glucocorticoid signaling and immune function. Validation showed that PLSR-based predictors outperform published blood-derived circadian phase predictors. When given one sample as input, the R2 of predicted vs observed phase was 0.74, whereas for two samples taken 12 hr apart, R2 was 0.90. This blood transcriptome-based model enables assessment of circadian phase from a few samples.DOI: http://dx.doi.org/10.7554/eLife.20214.001

Sleep Quality and Chronotype Differences between Elite Athletes and Non-Athlete Controls

“…While sleep quality is inherently subjective, objectively measurable correlates of poor sleep quality have been proposed, including frequency of arousals [41] and sleep discontinuity [42]. Likewise, while circadian phase preference is inherently subjective, the timing of the circadian pacemaker (biological clock) can be measured objectively based on the timing of the dim light melatonin onset [43] or, more recently, through transcriptome-based biomarkers in blood [44]. Thus, given sufficient resources, future research should be able to address questions about athletes' sleep disturbances and the underlying causes more definitively.…”

A single-sample circadian biomarker that performs across populations and platforms

“…Clinical use of circadian biomarkers will require fast, cost-effective, and non-invasive sampling techniques and an optimal detection platform. Finally, head-to-head comparisons are necessary to link the molecular clock phase predicted from skin biomarkers with the melatonin phase predicted from blood [11,[13][14][15]17] and other physiological phases (e.g., core body temperature) [29].…”

“…However, DLMO is inconvenient, costly, difficult to standardize, and thus rarely used 3 clinically. With the development of high-throughput molecular detection platforms and computational techniques, recent efforts shifted to machine learning predictions based on the transcriptome or metabolome from one or two samples of whole blood [11][12][13][14][15][16], or a specific blood cell type (e.g., CD14 + monocytes) [17]. Using these developed machine learning approaches, the DLMO phase (or sampling time) could be accurately assigned within 3 h from a single blood sample.…”

TimeTeller: a New Tool for Precision Circadian Medicine and Cancer Prognosis

“…Laing et al (32) published a study that uses a partial least squares regression method to estimate melatonin cycles from transcriptome data. They used a large, novel human transcriptome dataset, which consisted of timecourses of melatonin and gene expression in sleep deprived states.…”